Latest IGCS News
Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer
SEOUL, South Korea -- Treatment with the bispecific antibody ubamatamab alone or…
T-DXd Tied to Encouraging Survival in HER2-Expressing Gyn Cancers
SEOUL, South Korea -- Durable responses with trastuzumab deruxtecan (T-DXd; Enhertu) in…
Sexual Health Suffered After Radical Hysterectomy for Early Cervical Cancer
SEOUL, South Korea -- Women with low-risk, early-stage cervical cancer who underwent…
Mixed Results for Tiragolumab/Atezolizumab Combo in PD-L1+ Recurrent Cervical Cancer
SEOUL, South Korea -- Combining the novel anti-TIGIT monoclonal antibody tiragolumab with…
RAF/MEK and FAK Inhibitor Combo Effective in Low-Grade Serous Ovarian Cancer
SEOUL, South Korea -- The combination of avutometinib and defactinib achieved "exceptionally"…
Maintenance Selinexor May Boost PFS in TP53 Wild-Type Advanced Endometrial Cancer
SEOUL, South Korea -- Maintenance therapy with selinexor (Xpovio) seemed to substantially…
